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Aims. Synthetic meshes are the long-standing choice for the clinical treatment of abdominal wall hernias: the associated long-term
complications have stimulated the development of a new generation of bioresorbable prostheses. In this work, polycaprolactone
(PCL) porous membranes prepared by solvent casting/porogen leaching of PCL/poly(ethylene glycol) (PEG) blends with
diﬀerent compositions (diﬀerent PCL/PEG weight ratios and PEG molecular weights) were investigated to be applied in the
ﬁeld. An optimal porous membrane structure was selected based on the evaluation of physicochemical, biomechanical, and
in vitro biological properties, compared to a reference commercially available hernia mesh (CMC). Findings. Selected PCL7-2i
membranes, derived from PCL/PEG 70/30 (PCL: Mw 70,000-90,000Da; PEG: 35,000Da), showed suitable pore size for the
application, intermediate surface hydrophilicity, and biomimetic mechanical properties. In vitro cell tests performed on PCL7-2i
membranes showed their cytocompatibility, high cell growth during 21 days, a reduced production of proinﬂammatory IL-6
with respect to CMC, and a signiﬁcant secretion of collagen type I. Conclusions. PCL7-2i membranes showed biomimetic
biomechanical properties and in vitro biological properties similar to or even better than - in the case of anti-inﬂammatory
behavior and collagen production - CMC, a commercially available product, suggesting potentially improved integration in the
host tissue.
1. Introduction
Ventral hernias are one of most frequent problems associated
with major abdominal surgical procedures with an incidence
between 2 and 20% of patients [1], with a recurrence rate of
20-25% [2]. The high incidence of this side eﬀect generates
an important cost for national healthcare systems, with a
worldwide estimation of millions of hernia repairs every year
(20 millions only for inguinal hernia treatment) [3].
Hernia treatments include a series of options as suture
repair and prosthetic materials to reinforce the fascial
defect [4]. This last option has shown its potentiality, limit-
ing the recurrence rate with respect to suture repair [5, 6],
in particular delaying this risk of 2-3 years [7]. Currently,
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implantation of prostheses, able to support damaged tissue
in its mechanical and structural functions, represents the
care standard treatment. Main advantages of meshes are
related to their easy availability and resistance to patients’
tissue stresses [8, 9].
Synthetic meshes, commonly based on nonresorbable
polymers such as polypropylene (PP) and expanded polyte-
traﬂuoroethylene (ePTFE), are the long-standing choice in
clinical practice since their introduction in the 50s [10].
These materials are eﬀective in hernia treatment with respect
to surgical suture but can cause long-term complications
such as adhesion formation, graft infection/rejection, ﬁstula
formation, and hernia recurrence [11–13]. For all these rea-
sons, research in soft tissue engineering is aimed at realizing
a new generation of prostheses able to mimic mechanical
properties of host tissue and recreate a physiological environ-
ment for its cellular components [14]. One of the possible
improvements is development of scaﬀolds with resorbable
properties, in terms of ability to integrate in the host, promo-
tion of new tissue formation, and replacement after a well-
deﬁned period. Examples of these materials are VICRYL™®
(Ethicon Inc., Somerville, NJ, USA) and DEXON™® (Cov-
idien, Mansﬁeld, MA, USA), based on copolymer formula-
tions of poly(glycolic acid) and poly(lactic acid) (PLGA):
although able to promote tissue integration, they were rap-
idly degraded, causing recurrence of hernia due to tissue
strength loss [15–17].
Mechanical properties have been improved by Poly-
lactide Mesh® (Ethicon, San Lorenzo, PR, USA), based
on polylactide (95% lactide, 5% glycolide), which however
has shown a more severe inﬂammatory response [14].
TIGR® (Novus Scientiﬁc, Uppsala, Sweden), a multiﬁlament
mesh based on a fast-degrading PLGA and slow-degrading
poly(trimethylene carbonate) (PTMC), and GORE BIO-A®
(Gore, Newark, DE, USA), an electrospun mesh based
on polyglycolic acid (PGA)–PTMC copolymer, have shown
limited mechanical load-bearing properties during appli-
cation [14].
Phasix® (Bard, Warwick, RI, USA), a poly(4-hydroxybu-
tyrate) (P4HB) mesh, has also been introduced having a long
degradation time (>72 weeks in male Yucatan swine); how-
ever, its long-term in vivo response is unknown [14].
Additionally, bioresorbable polymers, such as polycapro-
lactone (PCL), polydioxanone (PDO), PLGA, poly(L-lactic
acid) (PLLA), and PCL/collagen blends, have been investi-
gated in scientiﬁc literature for the preparation of nanoﬁ-
brous surgical meshes [18]. Although nanoﬁber texture
mimics the extracellular matrix (ECM) structure and facili-
tates cell attachment, nanoﬁbrous membranes suﬀer from
poor mechanical properties and are unable to support the
abdominal wall pressure, especially as soon as the polymer
molecular weight decreases during degradation [18].
An alternative scaﬀold morphology to a typical ﬁlament
or nanoﬁbrous structure could oﬀer superior mechanical
properties allowing the use of bioresorbable polymers in the
treatment of abdominal hernia.
PCL, a member of polyesters of the poly(α-hydroxyl
acid) family, represents a promising candidate for biore-
sorbable hernia meshes. PCL is a US Food and Drug
Administration-approved polymer, with biocompatible and
biodegradable properties, able to favor attachment and
growth of diﬀerent cell types (ﬁbroblasts [19, 20], myoblasts
[21], chondrocytes [22], and smooth muscle cells [23]) and
is commonly used in diﬀerent biomedical applications [24].
In particular, PCL is widely used for the preparation of
scaﬀolds applied in reparative surgery as treatment of wound
healing [25].
In this work, polymeric blends based on PCL with poly
(ethylene glycol) (PEG) of two diﬀerent molecular weights
(PEG1:Mw 10,000Da; PEG2:Mw 35,000Da) were developed
for application in hernia treatment and tested for their
structural, mechanical, and biological properties compared
to a commercial product (CMC, Dipro Medical Devices, San
Mauro Torinese, Italy), used as a reference system [26].
The CMC is a nonresorbable composite prosthesis used
for ventral hernia repair and made up by a polypropylene
lightweight macroporous mesh sewn on a smooth polypro-
pylene ﬁlm. PEG is a polymer frequently used in tissue engi-
neering thanks to its nontoxicity properties, low protein
adhesion, absence of immunogenicity, and solubility in water
and organic solvents [27, 28]. In this work, PEG was used as a
porogen blend component. Polymeric blends were analyzed
for their physicochemical properties to evaluate morphology,
thermal behavior, chemical characteristics, surface wettabil-
ity, and tensile mechanical properties. In vitro cell tests using
human ﬁbroblasts, directly involved in the wound healing
process [29, 30], were performed to evaluate cell biocom-
patibility of materials in terms of cytotoxicity and cell
growth, inﬂammatory proﬁle, and modulation of ECM by
proteomic analysis.
The integration of biomechanical and biological char-
acterization is fundamental in the development of a new
generation of bioengineered scaﬀolds able to replicate and
mimic the host tissue characteristics.
2. Materials and Methods
2.1. Materials. PCL (Mw: 70,000-90,000Da) and PEG (Mw:
10,000Da and 35,000Da, coded as PEG1 and PEG2, respec-
tively) were supplied from Sigma-Aldrich (Milan, Italy), in
granular form. All solvents were of analytical grade and
used as received (Sigma-Aldrich, St. Louis, MO, USA).
CMC was gently furnished by Dipro Medical Devices (San
Mauro Torinese, Italy).
2.2. Scaﬀold Fabrication. Porous PCL membranes were pre-
pared using a solvent casting–leaching method. PCL/PEG1
and PCL/PEG2 100/0, 70/30, 60/40, and 0/100 (wt/wt)
blends were prepared using solution mixing. The polymers
were dissolved in chloroform at 10% (wt/v) concentration.
Membranes were obtained by casting a volume of each solu-
tion (10mL) on glass Petri dishes with 55mm diameter. The
solvent was removed via evaporation under a fume hood at
room temperature for a period of 48 h, and the dried mem-
branes were weighed (W0). Each membrane was then
immersed in deionized water for 48 h: water was replaced
after this time, and membranes were immersed in deionized
water for a further 24h to assure PEG leaching out. The
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obtained porous membranes were dried at 37°C for a period
of 24 h and weighed again (W f ). Samples codes are reported
in Table 1. The code for leached samples is “PCLx − yi,”
where x indicates the PCL amount in the initial PCL/PEG
blend (x = 7 or 6, indicating that the PCL content in the
initial blend was 70% or 60%, respectively), while y indicates
the PEG type used in the blend (y = 1 or 2, indicating PEG1
or PEG 2, respectively).
2.3. PEG Leached Out Percentage. The percentages of PEG
leached out from the membranes were calculated according
to the
PEG leached out % = W0 −W fPEG loadingweight ∙100, 1
whereW0 andW f are the weights of membranes before and
after leaching.
2.4. Scanning Electron Microscopy. Scanning electron micros-
copy (SEM LEO 1430, Zeiss, Milan, Italy) was performed on
the surface and fractured sections (in liquid nitrogen) of
membranes before and after PEG leaching. Samples were
sputter-coated with gold before SEM analysis. The accelerat-
ing voltage was 20 kV.
2.5. Diﬀerential Scanning Calorimetry. The thermal behav-
ior of membranes, before and after leaching, was investi-
gated by diﬀerential scanning calorimetry (DSC) using
TA Instruments DSC Q20 (Milan, Italy). Membrane sam-
ples (5-10mg) were weighed in aluminum pans, and noni-
sothermal scans were performed between −65°C and 100°C
(ﬁrst heating; cooling; second heating) at a heating rate of
10°C/min under nitrogen atmosphere. The melting temper-
ature (Tms) and enthalpy of fusion (ΔHms) of membranes
were measured from the second DSC heating scan whereas
crystallization temperature (TCs) and enthalpy (ΔHCs) were
obtained from the DSC cooling scan. The glass transition
temperature (Tgs) of PCL, PEG1, and PEG2 was not detected
because it was lower than the minimum temperature reach-
able by the employed DSC apparatus.
Leached membranes were also analyzed by DSC by heat-
ing them from room temperature to 120°C at 10°C/min to
test the eﬃciency of the drying procedure (24 h incubation
in an oven at 37°C). The lack of an endothermic peak at
100°C due to water evaporation was considered the evidence
of eﬀective drying.
2.6. Fourier Transform Infrared Spectroscopy. Chemical anal-
ysis of samples before and after leaching has been carried out
in a PerkinElmer Frontier Optical Spectrometer ﬁtted with
an attenuated total reﬂection sampler (FTIR-ATR, Milan,
Italy). Spectra were recorded over the 400-4000 cm−1 range
at room temperature, using diamond crystal, and 32 scans
were performed for each sample.
2.7. Contact Angle. The static contact angles of the sample
surfaces, before and after leaching, were determined through
a sessile drop method, using a 5μL double-distilled water
droplet. Static contact angles of membranes were mea-
sured in air at room temperature in a CAM 200 KSV
instrument (Milan, Italy) equipped with Attension Theta
software for data acquisition. The static contact angle value
was the average of 15 measures at random areas of each
sample membrane.
2.8. Tensile Testing. Mechanical properties of membranes
before and after leaching were evaluated by a tensile test on
rectangular specimens using the uniaxial tensile testing
machine ZwickRoell Z005 (Genoa, Italy). Samples presented
a similar size both in the cross-sectional area (thickness
0.35± 0.05mm, width 9.8± 0.2mm) and in the length
(13.5± 0.2mm). The tensile force was applied along the
length of the samples until fracture, using a preload of
0.05N and deformation speed of 0.05%/s. At least 5 speci-
mens for each type of membrane were tested. The elastic
modulus (E), stress at failure, and deformation at failure were
measured from the stress-strain curves, derived from the
force-displacement curves using a speciﬁc sample size. E
was evaluated as the slope of the ﬁrst linear part of the
stress-strain curve, and the failure stress and deformation
were calculated as the maximum stress a material can with-
stand and the corresponding deformation, respectively.
CMC mesh tensile mechanical properties were also ana-
lyzed by testing dry rectangular specimens (50× 300mm) in
a MT® QTest™/10 instrument (Turin, Italy). The traction
force was applied along the length of the samples, at a
constant cross-head displacement rate of 100mm/min. At
least 5 specimens were tested. Failure stress and failure defor-
mation were measured from the stress-strain curves, while
E was not evaluated due to the nonhomogeneous structure
of samples, characterized by mesh holes.
2.9. Cell Culture. BJ human skin ﬁbroblasts (ATCC-CRL-
2522, Teddington, UK) were cultured in minimum essential
medium (MEM) supplemented with 10% fetal bovine
serum (FBS), 2mM L-glutamine, 100μU/mL penicillin,
10-1μU/mL streptomycin, and 2.5× 10-1μU/mL amphoter-
icin B. All these products were purchased at Sigma-Aldrich
(St. Louis, MO, USA). Cells were ampliﬁed up to reaching
conﬂuence (34000 cells/cm2), and, during this period, the
medium was changed every 3 days.
2.10. Cytotoxicity. Cytotoxicity tests were conducted accord-
ing to the ISO 10993-5 standard. In this study, membranes of
Table 1: Samples nomenclature before and after the PEG leaching
process.
Before leaching After leaching
PCL PCL
PEG1 —
PEG2 —
PCL/PEG1 70/30 PCL7-1i
PCL/PEG1 60/40 PCL6-1i
PCL/PEG2 70/30 PCL7-2i
PCL/PEG2 60/40 PCL6-2i
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each material after leaching (18 cm2 surface) were sterilized
with 70% ethanol and ultraviolet (UV) radiation treatment
(20minutes for each side) and then incubated at 37°C for
24 h in 3mL of MEM complete medium. The medium was
then extracted for further in vitro cell tests (extract medium).
The positive control was a complete medium supplemented
with 5% dimethyl sulfoxide (DMSO) (v/v). As negative con-
trol, cells cultured in standard medium were used.
Cells were seeded at conﬂuence in a 96-well plate
(~10.000 cells/well), and, once adhered, 200μL of the
medium was exchanged with the extract medium. Cells were
placed in an incubator, and, after exposure to the extract
medium for 72 h at 37°C, changes of cellular morphology
were evaluated under an AX70 light-reverted microscope
(Olympus, Milan, Italy) and cell viability tests were per-
formed by using Promega CellTiter Blue® (Madison, WI,
USA). In each well, 100μL of fresh media was added together
with 10μL of reagent. After 150 minutes, the relative ﬂuores-
cent unit (RFU) values were evaluated with a spectrophotom-
eter plate reader (579ex/584em). Materials with a viability
value of at least 70% were selected for cell culture growth pro-
ﬁle evaluation.
2.11. Cell Culture Growth. Membranes were sterilized with
70% ethanol and UV radiation treatment (20 minutes for
each side) and left in contact with the medium for 2 hours
before cell seeding. Cells at conﬂuence were washed with
phosphate-buﬀered saline (PBS), detached by trypsin
(0.25% (w/v)), and placed in contact with a fresh complete
medium to deactivate enzyme action. Fibroblasts were
counted with a hemocytometer and seeded on materials,
placed in a 6-well plate at a cell density of 15% (equivalent
to ~50.000 cells/well). At well-deﬁned time (3, 7, 14, and 21
days) cell viability test was performed with CellTiter Blue®.
In order to count cells, a standard curve of ﬁbroblasts on
culture plates was obtained. Cells were seeded in 24-well
plates at several concentrations (from 5000 to 70,000 cells/
well), in duplicate. Once adhered, 50μL of CellTiter Blue®
was added to each well and, after 150 minutes, RFU emitted
by dye was evaluated as above.
At the 21st day, samples were ﬁxed with 4% paraformal-
dehyde solution for 30 minutes at room temperature and
preserved in PBS at 4°C for immunohistochemistry protocol.
2.12. Cytokine Production. The medium at 7, 14, and 21 days
was collected and stored at -80°C until cytokine analysis. IL-6
quantiﬁcation was performed by use of Elecsys IL-6 assay
(Roche Diagnostics, Milan, Italy), an electrochemiolumines-
cent immunoassay (ECLIA).
Analysis of IL-10 was performed using ELISA kit assay
(Boster Biological Technology, Fremont, CA, USA).
2.13. Immunohistochemistry. Paraformaldehyde-ﬁxed sam-
ples were treated for evaluation of collagen type I and
type III production. Collagen type I was recognized by
anti-human COL1A1 goat primary antibody and relative
FITC-conjugated secondary antibody (donkey anti-goat
IgG-FITC); collagen type III was identiﬁed by anti-human
COL3A1 goat primary antibody and relative rhodamine-
conjugated secondary antibody (bovine anti-rabbit IgG-R).
All the antibodies were purchased at Santa Cruz Biotechnol-
ogy (Dallas, TX, USA). Samples were washed three times
with PBS and treated with 0.1% Triton in PBS for 2 minutes
at room temperature to permeabilize cell membranes.
Samples were left in 5% BSA for 30 minutes and then treated
with a mix of the two primary antibodies, 1 : 100 diluted in
1% BSA, for 1 hour at 37°C. Then, a mix of the secondary
antibodies 1 : 200 diluted in 1% BSA was added to the
samples for 1 hour at 37°C. Fifteen minutes before the end
of incubation, DAPI (4′,6-diamidino-2-phenylindole) was
added to each sample at 1 : 1000 dilution to detect cell nuclei.
Finally, samples were analyzed by means of a ﬂuorescence
microscope (CX40, Olympus, Milan, Italy).
2.14. ECM Extraction. Cells were seeded on PCL7-2i mem-
branes and CMC mesh and cultured for 7 days. Cells were
removed and ECM recovered as described in [26].
2.15. Sample Processing and Liquid Chromatography-
Tandem Mass Spectrometry with SWATHTM–Based Analysis
(LC-MS/MS SWATH) for Proteomics. For sample treatment
and LC-MS/MS analysis, the same protocol described in
Vozzi et al. [26] was used. Brieﬂy, protein concentration
was determined by bicinchoninic acid assay (Pierce, Thermo
Scientiﬁc, Waltham, MA, USA). About 40mg of protein
was dissolved in ammonium bicarbonate 25mM, reduced
with dithiothreitol 5mM at 80°C for 30min, and alkylated
using iodoacetamide 10mM at 37°C for 20min. Digestion
was obtained incubating overnight with 1 : 100 Trypsin
(Roche, Basel, Switzerland): substrate at 37°C. Peptide mix-
tures were acidiﬁed and then loaded on a C18 cartridge in
order to eliminate debris and additionally puriﬁed with
0.22μm ﬁlters. Peptides were diluted to 0.1μg/μL by 2%
acetonitrile (ACN, Romil, UK)/0.1% formic acid (FA);
5μL was injected for library searching and 2μL in duplicate
for SWATH™ method analysis.
Chromatographic separation of peptides was performed
using a nano-HPLC system (Eksigent, AB Sciex, Washing-
ton, DC, USA). Peptides eluted from chromatography were
directly processed using a 5600 TripleTOF™mass spectrom-
eter (AB Sciex) equipped with a DuoSpray™ ion source (AB
Sciex). Data were acquired using the SWATH™ method for
shotgun data-independent MRM quantiﬁcation. For library,
MS/MS data were processed with ProteinPilot™ Software
(AB Sciex). The false discovery rate (FDR) analysis was set
to a conﬁdence level of 95%.
2.16. Statistical Analysis. All data were expressed as mean ±
standard deviation obtained by at least ﬁve diﬀerent experi-
ments. Diﬀerences between groups were evaluated by one-
way ANOVA and Student t-test; Prism 7 software was used
for statistical analysis. Values were considered statistically
signiﬁcant for p value <0.05. For proteomics data, to evaluate
diﬀerentially expressed proteins between CMC and PCL7-2i
at 7 days, MarkerView 1.2 software was used. Three technical
replicates for biological sample were used. The two groups
were compared by t-test statistics: paired t-test was used as
a statistical parameter between the means of continuous
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variables to determine signiﬁcant diﬀerences between the two
categories of mass spectrometric data. A p value <0.05 and a
fold change > 2 were considered signiﬁcant to validate diﬀer-
ences between categories.
3. Results
3.1. PEG Leached Out Percentage. Incubation of PCL/PEG1
and PCL/PEG2 blend ﬁlms in a water bath almost caused
an approximately complete dissolution of the PEG compo-
nent leaving porous membranes (Table 2). The percentage
of leached out PEG corresponds to the porosity degree of
membranes. A small percentage of PEG with respect to the
initial amount was still present in blends (Table 2).
3.2. Morphological Characterization by Scanning Electron
Microscopy (SEM). Figure 1 shows the SEM images of the
external surface and fractured section of PCL/PEG1 and
PCL/PEG2 blends.
Blend ﬁlms showed a compact section. No evident phase
separation between blend components was observed in any
of the blend compositions.
Morphological evaluation was also conducted on PCL-
based membranes after PEG dissolution (Figure 1). Surfaces
were scarcely porous. On the contrary, fractured sections
were highly porous with homogeneous distribution of pores
with spherical shape.
3.3. Thermal Properties by Diﬀerential Scanning Calorimetry
(DSC). The ﬁrst heating scan of leached samples conﬁrmed
the complete lack of water as the endothermic peak associ-
ated with water evaporation was not present (data not
shown). Hence, the eﬃciency of the employed drying proto-
col (sample incubation for 24 h at 37°C) was demonstrated.
Figure 2 collects DSC second heating thermograms for
PCL, PCL/PEG1, and PCL/PEG2 ﬁlm samples before and
after PEG removal. The analysis of the second heating scan
allows a comparison of material properties after deleting
the thermal history.
PEGs and PCL are semicrystalline polymers character-
ized by a melting temperature (Tm). PEG and PCL glass tran-
sition temperatures could not be detected by DSC analysis, as
they are both at -67°C [31], corresponding to the limit cool-
ing temperature of the DSC instrument used in this work.
For each blend, a double melting peak (Table 3) was
detected, due to the diﬀerent melting temperatures of the
blend components. In blends, Tm of PCL phase did not vary,
while a slight decrease was observed for the melting peaks of
PEG1 and PEG2 phases with respect to pure PEGs (Figure 2,
B1 and B2).
The cooling scans of PCL, PEG1, and PEG2 samples
showed a crystallization event (Figure 2, A1 and A2). On
the contrary, PCL/PEG1 blend ﬁlms were characterized by
three Tc (Table 3): the lower Tc was related to the crystalliza-
tion by homogeneous nucleation of PEG1 (1.6± 0.1°C for
PCL/PEG1 70/30 and 2.4± 0.2°C for PCL/PEG1 60/40), the
intermediate Tc was due to PCL crystallization (at around
23°C), and the higher Tc was associated to PEG1 heteroge-
neous nucleation (35.5± 0.4°C for PCL/PEG1 70/30 and
39.1± 1.4°C for PCL/PEG1 60/40) [32]. In blends, Tc values
of PEG1 and PCL (considering for PEG1 the heterogeneous
crystallization only) decreased compared to the pure poly-
mers. The presence of the homogeneous PEG1 nucleation
mechanisms was ascribed to a ﬁne dispersion of PEG1 in
the PCL matrix.
For blends containing PEG2, the crystallization of PEG2
through two diﬀerent nucleation mechanisms, homogeneous
and heterogeneous, was observed only for PCL/PEG2 60/40
blend ﬁlms, respectively, at 1.4± 0.4°C and 40.0± 0.7°C. Sim-
ilarly to that observed for PCL/PEG1 blends, Tc values of
PCL and PEG2 (considering crystallization by heterogeneous
nucleation mechanism for PEG2 in PCL/PEG2 60/40 blends)
slightly decreased with respect to pure polymers.
On the other hand, the PCL/PEG2 70/30 blend only
showed PEG2 crystallization by homogeneous nucleation.
Hence, PCL/PEG2 70/30 blend samples only showed two
distinct Tc at about 1.5
°C (crystallization of PEG2 by homo-
geneous nucleation) and 25°C (crystallization of PCL). The
presence of a unique crystallization temperature for PEG2
phase could be due to a ﬁner dispersion of PEG2 in the
PCL matrix (Table 3).
After PEG removal, all the membranes showed only a
characteristic thermal event, both in the cooling scan and in
the second heating scan, attributed to PCL crystallization
and melting, respectively. In porous membranes, the cooling
and melting enthalpies of PCL were slightly higher compared
to the values of control PCL samples, suggesting a slightly
higher crystallization degree of porous membranes.
After PEG dissolution (Table 3), the characteristic
thermal transitions associated with PEG phase could not
be detected. This could be due to a complete removal of
PEG or to the permanence of a very small amount of
PEG which thermal transitions cannot be detected by
DSC analysis.
3.4. Chemical Analysis by FTIR-ATR. Characteristic FTIR-
ATR absorption bands (Supplementary Material Figure S1)
of PCL and PEG could be detected in the FTIR-ATR
spectra of blend ﬁlms. In particular, a sharp band at around
1726 cm−1 was observed, corresponding to the carbonyl-
stretching of PCL. When the content of PEG increased, no
appreciable shift of this band was observed suggesting poor
interaction between the phases.
After PEG removal, absorption bands attributed to the
PEG2 component were no more detected in the FTIR-ATR
spectra of porous ﬁlms, such as the asymmetric stretching
vibrations of C-O-C bonds at around 1280 cm−1. This result
Table 2: Percentage of weight loss in blends due to PEG dissolution
and percentage of undissolved PEG with respect to the initial PEG
amount.
Samples Weight loss after leaching (%) Undissolved PEG (%)
PCL7-1i 29.4± 0.6 2.0± 0.2
PCL7-2i 28.8± 0.6 4.0± 0.2
PCL6-1i 38.9± 0.3 2.8± 0.8
PCL6-2i 38.8± 0.0 3.0± 0.0
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conﬁrmed the complete removal of porogen from PCL/PEG
blend ﬁlms (Supplementary Material Figure S1).
3.5. Surface Wettability Properties. Table 4 collects the static
contact angle for all samples, before and after leaching. PCL
samples (73.1± 2.8°) were markedly less hydrophilic than
PEG1 (41.5± 2.9°) and PEG2 (44.0± 1.9°) samples (for both
comparison, p < 0 05). The surface static contact angle of
PCL/PEG1 cast ﬁlms decreased as the amount of PEG1
increased: it was 71.5± 2.4° for blends containing 30%wt.
PEG1 and 44.7± 2.6° for blend containing 40%wt. PEG1.
On the contrary, the static contact angle of PCL/PEG2 blend
samples did not change signiﬁcantly with increasing PEG2
content (49.1± 3.0° for PCL/PEG2 70/30 and 51.2± 2.5° for
PCL/PEG2 60/40), although it was lower than for PCL.
After leaching, surface wettability decreased for all the
samples. Porous ﬁlms with PEG1 as porogen showed the
highest contact angle values (110.0± 6.8° for PCL7-1i and
82.9± 7.4° for PCL6-1i) while PCL7-2i and PCL6-2i retained
surface hydrophilicity with contact angles of 67.8± 3.9° and
66.8± 6.1°.
3.6. Mechanical Characterization. The mechanical properties
of the tested materials including the elastic modulus, the
maximum load, and the deformation at maximum load are
reported in Figure 3.
Surface Fractured sections
Before leaching After leaching Before leaching After leaching 
(1) (2)
(3) (4) (5) (6)
(7) (8) (9) (10)
(11) (12) (13) (14)
(15) (16) (17) (18)
20 휇m Mag = 2.00 K X Fill = 3.057 AEHT = 20.00 kV
WD = 10 mm
Signal A = SE1
20 휇m⁎ Mag = 500 X Fill = 2.960 AEHT = 15.00 kV
WD = 10 mm
Signal A = SE1
20 휇m Mag = 2.00 K X Fill = 3.057 AEHT = 20.00 kV
WD = 10 mm
Signal A = SE1
20 휇m⁎ Mag = 2.00 K X Fill = 2.914 AEHT = 20.00 kV
WD = 15 mm
Signal A = SE1
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Figure 1: SEM images of the surface and fractured sections of materials before (odd numbers) and after (even numbers) leaching: PCL (1, 2),
PCL/PEG1 70/30 (3, 5), PCL7-1i (4, 6), PCL/PEG1 60/40 (7, 9), PCL6-1i (8, 10), PCL/PEG2 70/30 (11, 13), PCL7-2i (12, 14), PCL/PEG2 60/40
(15, 17), and PCL6-2i (16, 18). Scale bar = 20μm for surfaces and 10 μm for section images.
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The elastic modulus increased with increasing PCL con-
tent (Figure 3(a)). The elastic modulus of PCL/PEG2 blends
was higher than that of PCL/PEG1 blends with the same
composition. The same trend is conﬁrmed after the leaching
process: PEG2-derived samples have a higher elastic modulus
than the corresponding PEG1-derived ones. In both cases,
the leaching process leads to less rigid structures with respect
to nonleached samples.
Similarly, failure stress increased with increasing content
of PCL (Figure 3(b)), with higher values for PCL/PEG2
blends, for both leached and nonleached samples. The leach-
ing process decreases the failure stress. The stress at failure of
CMC was 2.4± 0.3MPa.
Before leaching, the deformation at failure (Figure 3(c))
was similar for all blend samples and signiﬁcantly lower than
that of pure PCL. After leaching, samples showed higher
deformability: particularly, PCL/PEG2-based blends had
higher failure deformation. CMC deformation at failure was
49.1± 3.5%, signiﬁcantly higher than for PCL samples.
3.7. In Vitro Cytotoxicity. Cytotoxicity tests showed that all
the porous and nonporous materials presented after 3 days
the same viability (>95%) with respect to negative control
(untreated cells, 100%) and to CMC (>95%), with values
above the threshold of 70% indicated by ISO 10993-5 (data
not shown).
3.8. In Vitro Cell Growth Tests. The tests were only performed
on porous samples, as for the PCL/PEG blends: PEG would
be released in the culture medium during the test, and their
elastic modulus was too high with respect to reference
meshes for hernia prostheses [33]. Results showed that only
PCL7-2i presented a good cell growth trend, with a continu-
ous increase in cell viability (Figure 4) superimposable to
control and CMC.
3.9. Inﬂammatory Proﬁle. Based on the results of cytocom-
patibility and cell growth tests, PCL7-2i membranes were
selected to perform the analysis on inﬂammatory proﬁle by
anti- (IL-10) and pro- (IL-6) inﬂammatory markers. As
shown in Figure 5, the initial anti-inﬂammatory proﬁle of
PCL7-2i (Figure 5(a)) was substituted by a proinﬂammatory
trend (Figure 5(b)), with IL-6 ﬁnal concentration 4 times
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higher with respect to day 7, but with reduced levels with
respect to CMC.
3.10. Immunohistochemistry. Finally, also type I and type III
collagen production was semiquantitatively evaluated with
immunohistochemistry and the type I collagen/type III colla-
gen ratio quantiﬁed. In control conditions, BJ ﬁbroblast cells
produced type III collagen (neo-formed type) and, in small
quantity, type I (stable) collagen (Figure 6(a)). PCL7-2i
reduced the production of type III collagen favoring a strong
and signiﬁcant increase (±3 times, p < 0 0001) of type I colla-
gen. This trend was also conﬁrmed by the type I collagen/
type III collagen ratio (Figure 6(b)), which showed a value
near 0.8 (p < 0 0001).
3.11. ECM Protein Characterization. ECM proteins were
extracted from CMC and PCL7-2i membranes and analyzed
by mass spectrometry that allowed the identiﬁcation of 243
proteins (Supplementary Material Table S1). Proteins were
classiﬁed according to their localization (Supplementary
Material Figure S2), and up to 125 were ECM, ECM-
associated, or membrane proteins. Of these, four resulted to
be diﬀerentially expressed when samples from CMC and
PCL7-2i were compared (Table 5).
4. Discussion
This work was aimed at the preparation and characterization
of porous PCL membranes to be used as a new generation
of resorbable hernia meshes. Particularly, porous PCL
membranes were characterized for their physicochemical,
mechanical, and biological characteristics, comparing results
with the performance of a commercially available CMC
mesh: this lightweight polypropylene mesh is able to favor
cell colonization, generating a series of biochemical modiﬁca-
tions in terms of typical inﬂammatory reaction, collagen pro-
duction, and ECM expression [26]. However, the lightweight
mesh is not suitable to prevent adhesion to internal organs
[34]. On the contrary, the polypropylene ﬁlm does not
induce the formation of adhesion to viscera due to its plane
surface and its antiadhesive features shown in Wistar rats
[33] and in clinical studies [35, 36].
In our work, porous membranes with an asymmetric
structure characterized by a poorly porous skin layer and
high internal porosity were obtained. As the amount of
dissolved PEG was approximately equal to the amount of
incorporated PEG, the porosity degree was 29.4± 0.7% and
28.8± 0.6% for PCL7-1i and PCL7-2i samples and 38.9±
0.3% and 38.8± 0.0% for PCL6-1i and PCL6-2i, respectively.
PCL and PEG have a diﬀerent polarity (PCL is poorly hydro-
philic while PEG is highly hydrophilic as suggested by con-
tact angle measurements) and consequent weak reciprocal
interactions: for this reason, the PEG phase formed spherical
dispersed domains in the PCL matrix, leading to spherical
pores of approximately 5μm size after PEG removal. Addi-
tionally, the pore surface was smooth. These results sug-
gested that PEG and PCL were immiscible, which was in
agreement with previous ﬁndings in the scientiﬁc literature
[37]. Indeed, FTIR-ATR analysis showed that the carbonyl
stretching band of PCL did not shift as a function of blend
composition, conﬁrming poor interaction between blend
components. This result suggested that any interaction
between PCL and PEG2 was weak, and this conclusion was
consistent with DSC data. However, this result was opposite
to the ﬁndings by Ozeki et al. [38] who found interactions
between PEG and a carboxyvinyl polymer, having the same
carboxyl functional group of PCL. Probably, the diﬀerent
polarities between PEG and PCL (PEG is highly hydrophilic
while PCL is poorly hydrophilic as suggested by static con-
tact angle measurements) hindered the formation of a suﬃ-
ciently high number of hydrogen bonding to detect shifts of
the PCL carbonyl FTIR-ATR band.
Thermal characterization by DSC analysis showed that
the presence of partially crystallized PEG phase in blends
decreased the PCL phase crystallization rate, causing a slight
decrease in PCL Tc. This result was not observed for PCL/
PEG2 70/30 blends where PEG2 was still in a molten state
during PCL crystallization, while it underwent crystalliza-
tion at lower temperature than PCL by a homogeneous
nucleation mechanism. On the other hand, the PCL crystal-
lization degree slightly increased in porous membranes with
respect to compact PCL ﬁlms, suggesting some nucleating
eﬀect of PEG component. However, the Tm of the PCL
phase remained unchanged in blends before and after PEG
removal, suggesting that the perfection degree of PCL crys-
tals was similar in all the samples.
Importantly, DSC analysis suggested a diﬀerent inter-
action between blend components, depending on the molec-
ular weight of PEG: a higher amount of PEG tended to
crystallize by a homogeneous crystallization mechanism in
PCL/PEG2 blends vs. PCL/PEG1 blends with the same com-
position, as suggested by the corresponding crystallization
enthalpy values. The homogeneous crystallization behavior
of PEG2 in PCL/PEG2 blends was indicative of a distribu-
tion of PEG2 in domains with smaller size compared to
the PEG1 ones in PCL/PEG1 blends. This diﬀerence was
attributed to the higher molecular weight of PEG2 with
respect to PEG1: during solvent evaporation for membrane
formation, coalescence phenomena of PEG2 phase were par-
tially hindered by its higher molecular weight. Hence, PEG2
domains retained a smaller size compared to PEG1 domains
in PCL/PEG1 blends.
Porous ﬁlms obtained using PEG1 as porogen showed
surface hydrophobicity (static contact angle of 110.0± 6.8°
Table 4: Static contact angle values of samples before and after
leaching.
Before leaching
Contact
angle (°)
After
leaching
Contact
angle (°)
P value
PCL 73.1± 2.8 — — —
PEG1 41.5± 2.9 — — —
PEG2 44.0± 1.9 — — —
PCL/PEG1 70/30 71.5± 2.4 PCL7-1i 110.0± 6.8 <0.0001
PCL/PEG1 60/40 44.7± 2.6 PCL6-1i 82.9± 7.4 <0.0001
PCL/PEG2 70/30 49.1± 3.0 PCL7-2i 67.8± 3.9 <0.0001
PCL/PEG2 60/40 51.2± 2.5 PCL6-2i 66.8± 6.1 0.0007
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for PCL7-1i) or poor hydrophilicity (static contact angle of
82.9± 7.4° for PCL6-1i). On the other hand, PCL7-2i and
PCL6-2i were more hydrophilic with contact angles of 67.8±
3.9° and 66.8± 6.1°, respectively. The diﬀerent types of dis-
persion for PEG1 and PEG2 in PCL/PEG blends were prob-
ably the cause for a diﬀerent organization of PCL chains
on the surface: in the case of porous samples from PCL/
PEG2 blends, hydrophilic carboxylic moieties were proba-
bly preferentially distributed on the sample surface. Addi-
tionally, diﬀerences in surface morphology also aﬀected
surface wettability.
Mechanical analysis was performed on PCL/PEG
membranes and porous PCL ﬁlms (Figure 3), in order to
characterize and select biomechanical features similar to
meshes for hernia repair currently used in clinics. Meshes
should be strong enough to resist the state of stress pres-
ent in the adnominal wall and at the same time not so stiﬀ
to cause discomfort and pain to patients. Literature refer-
ence values for the elastic modulus of hernia meshes are
20-120MPa [33].
The elastic modulus increased with increasing PCL
content, both before and after the leaching process. The
molecular weight of PEG had inﬂuence on mechanical
properties: the elastic modulus of PEG2-derived blends
(PEG2: 35000Da) was higher than that of PEG1-derived
ones (PEG1: 10000Da).
Interestingly, the elastic modulus of the PCL/PEG2 70/30
blend was higher with respect to that of PCL, while the elastic
modulus of the PCL/PEG1 70/30 blend was signiﬁcantly
lower with respect to that of PCL. This behavior was probably
due to the diﬀerent interaction degrees between blend com-
ponents and the diﬀerent blend morphologies when using
PEGs with diﬀerent molecular weights. Indeed, DSC analysis
suggested that the PEG2 component was ﬁnely distributed in
the PCL/PEG2 70/30 blend; this was probably the reason for
its superior mechanical performance respect to the PCL/
PEG1 70/30 blend. After the leaching process, the elastic
modulus of porous samples obtained from PCL/PEG2 blends
was higher than for samples prepared from PCL/PEG1
blends, again suggesting a ﬁner and more homogeneous pore
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Figure 3: Comparative analysis of elastic modulus (a), failure stress (b), and failure deformation (c) for PCL/PEG blends before and after
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morphology. In both cases, after leaching, the resulting
porous structures present an elastic modulus signiﬁcantly
lower than that of the corresponding nonleached samples.
Similarly, the failure stress increased with increasing PCL
content (Figure 3(b)) due to the superior mechanical perfor-
mance of PCL with respect to PEG in nonleached blends and
due to the lower porosity in the case of leached samples.
As for the elastic modulus, the failure stress of PCL/
PEG2 was higher with respect to PCL/PEG1 blends, both
before and after leaching. This behavior, again, can be
addressed to a diﬀerent pore morphology, depending on
the molecular weight of PEG. The leaching process increases
the deformation at failure (Figure 3(c)), which presented
marked lower values in nonleached samples with respect to
pure PCL samples, again suggesting a more homogeneous
and ﬁner pore structure.
As a conclusion, higher concentrations of PEG resulted
into more porous and less stiﬀ membranes, but interestingly
PEG with the highest molecular weight (PEG2) resulted to be
more ﬁnely dispersed and led to stiﬀer structures. After
leaching, the membranes showed an elastic modulus in the
same range of meshes for hernia prosthesis and thus suitable
for applications in hernia repair. This is the ﬁrst time that the
solvent-casting/porogen leaching technique of PCL/PEG
blends is exploited for the preparation of scaﬀolds with suit-
able properties for the treatment of abdominal wall hernia
and as an alternative to electrospun scaﬀolds or ﬁlament-
based meshes [14].
For biological characterization, BJ human skin ﬁbroblasts
were selected for tests on materials under investigation,
according to their role in the wound healing process. In fact,
they represent a cell barrier respect to prosthesis, regulate
reparative process by secretion of growth factors, and modu-
late the surrounding cell environment [39].
All the samples showed an optimal cell biocompatibility
compared to the negative control. Cell growth analysis,
performed on porous samples, allowed a further selection
of materials under investigation. In fact, PCL6-1i, PCL6-2i,
and PCL7-1i showed nonadhesive and nonproliferative cell
properties, while PCL7-2i was characterized by progressively
increasing cell colonization on its surface. Hydrophobic-
ity together with mechanical and structural properties of
PCL7-2i seems to produce a positive eﬀect on its capabilities
to support cell colonization.
Based on these results, PCL7-2i membranes were selected
for further analyses. The inﬂammatory proﬁle showed an ini-
tial increase of the anti-inﬂammatory IL-10 cytokine [40]
followed by a strong increase of the proinﬂammatory one,
IL-6 [41], with reduced the magnitude with respect to
CMC. This trend was highlighted in our previous work [26]
and in literature [42]: inﬂammation is a typical body
response to surgery implant and can support mesh coloniza-
tion and integration [43]. This type of response probably
could be related to their surface and mechanical properties,
which, interacting with cells, modulate their chemomechani-
cal signal integration and stiﬀness sensing and stimulate the
secretion of inﬂammatory mediators [44, 45].
The biological characterization of PCL7-2i foresaw the
immunohistochemical analysis of two of the main compo-
nents of ECM produced by ﬁbroblasts: collagen I and colla-
gen III. PCL7-2i stimulated the production, at 21 days, of
mature collagen type I with respect to type III in comparison
to control and CMC mesh, conﬁrmed also by the collagen
type I/III ratio (value near 0.8). These two proteins are
heavily involved in mesh integration during prosthesis
implant where a remodeling process produces an initial
increase in the secretion of immature type III, followed by
production of mature type I [46–48]. Literature showed
how a decreased ratio could be of signiﬁcant importance in
the hernia pathophysiology probably leading to structural
and mechanical stability alteration of mesh in the host tissue
[49]. The increased production of collagen type I observed in
our experimentation and results of the inﬂammatory proﬁle
suggest a potential stable in vivo mesh implant favoring tis-
sue integration of and a contemporary reduction of host
rejection processes.
Interestingly, proteomics analyses were validated and, at
the same time, conﬁrmed the histological data: among the
diﬀerentially expressed proteins (Table 5), collagen type III
resulted to be signiﬁcantly overexpressed at day 7 in ECM
from PCL7-2i compared to CMC mesh. In our previous
paper [26], it was highlighted that major changes in ECM
deposition and modulation occurred during the ﬁrst 14 days
and, for these reasons, we focused on day 7 after cell seeding
for mass spectrometry analyses. Besides collagen type III, also
myosin regulatory light chain 12B and 78 kDa glucose-
regulated protein resulted to be overexpressed on PCL7-2i,
while 60 kDa heat shock protein was downregulated.
Myosin regulatory light chains are important for the
maintenance of cell morphology and dynamic [50]. 78 kDa
glucose-regulated protein is a endoplasmatic reticulum (ER)
chaperone involved in assembly and quality control of pro-
teins [51]. It is expressed on the cell membrane and
released in the cell culture medium [52], and its synthesis
is induced by the accumulation of unfolded polypeptides
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in the ER. It is interesting that this protein is overexpressed
in cancer and stressed cells, in which it can be actively
secreted and assume roles in controlling cell signaling,
proliferation, invasion, inﬂammation, and apoptosis [53].
Its induction and secretion on PCL7-2i could represent a
useful answer to a stress state, leading to cell proliferation
and invasiveness of the membrane. Also, the 60 kDa heat
shock protein is a chaperonin mainly involved in mito-
chondrial protein folding and translocation, but it is also
suggested as a danger signal of stressed or damaged cells
[54]. This protein resulted to be slightly underrepresented
on PCL7-2i.
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Figure 6: Collagen type I and type III production ((a); ∗ and ∗∗ p < 0 0001) and in collagen type I/type III ratio ((b); ∗ p < 0 0001) in PCL7-2i
and control samples.
Table 5: Diﬀerentially expressed proteins in ECM protein analysis.
Gene name Protein name t-test P value Fold change
GRP78_HUMAN 78 kDa glucose-regulated protein -35.557 0.00079 0.468 Upregulation in PCL7-2i
CO3A1_HUMAN Collagen alpha-1 (III) chain -12.545 0.00629 0.447 Upregulation in PCL7-2i
ML12B_HUMAN Myosin regulatory light chain 12B -10.756 0.00853 0.417 Upregulation in PCL7-2i
CH60_HUMAN 60 kDa heat shock protein, mitochondrial 4.495 0.04608 3.388 Downregulation in PCL7-2i
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This work represents the ﬁrst step for the development of
a new generation of resorbable hernia scaﬀolds. In particular,
a porous PCL membrane (PCL7-2i) was selected among four
diﬀerent PCL porous membranes, based on its physicochem-
ical and biomechanical properties, cytocompatibility, and cell
growth properties, and then further characterized for its
detailed biological behavior. Results showed that the PCL7-
2i membrane could be potentially applied in abdominal wall
hernia treatment. In fact, the analysis of biological response
of PCL7-2i membranes showed that this type of scaﬀold is
able to mechanically and structurally replicate the reference
tissue and to support cell colonization. This was highlighted
by the high cell growth rate on the scaﬀold, its minimal
inﬂammatory response, potentially avoiding undesirable
side eﬀects, and its modulation of ECM synthesis with the
support of stable forms of collagen and of proteins related
to cell proliferation and colonization. All these aspects could
contribute to scaﬀold integration.
Further tests will be aimed at the in vivo validation
of PCL7-2i in order to evaluate its eﬀectiveness in surgi-
cal treatment.
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